Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8; 21)(q22; q22)
MR Baer, CC Stewart, D Lawrence… - Blood, The Journal …, 1997 - ashpublications.org
Although acute myeloid leukemia (AML) with t (8; 21)(q22; q22) is associated with a high
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8; 21)(q22; q22)
MR Baer, CC Stewart, D Lawrence, DC Arthur… - …, 1997 - ohiostate.elsevierpure.com
Although acute myeloid leukemia (AML) with t (8; 21)(q22; q22) is associated with a high
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
[HTML][HTML] Expression of the Neural Cell Adhesion Molecule CD56 Is Associated With Short Remission Duration and Survival in Acute Myeloid Leukemia With t (8; 21) …
MR Baer, CC Stewart, D Lawrence, DC Arthur, JC Byrd… - Blood, 1997 - Elsevier
Although acute myeloid leukemia (AML) with t (8; 21)(q22; q22) is associated with a high
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
Expression of the Neural Cell Adhesion Molecule CD56 Is Associated With Short Remission Duration and Survival in Acute Myeloid Leukemia With t (8; 21)(q22; q22)
MR Baer, CC Stewart, D Lawrence, DC Arthur, JC Byrd… - Blood, 1997 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Although acute myeloid leukemia (AML) with t
(8; 21)(q22; q22) is associated with a high complete remission (CR) rate and prolonged …
(8; 21)(q22; q22) is associated with a high complete remission (CR) rate and prolonged …
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8; 21)(q22; q22)
MR Baer, CC Stewart, D Lawrence, DC Arthur… - …, 1997 - pubmed.ncbi.nlm.nih.gov
Although acute myeloid leukemia (AML) with t (8; 21)(q22; q22) is associated with a high
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
[引用][C] Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid Leukemia with t (8; 21)(q22; …
MR BAER, CC STEWART, D LAWRENCE… - Blood, 1997 - pascal-francis.inist.fr
Expression of the neural cell adhesion molecule CD56 is associated with short remission
duration and survival in acute myeloid Leukemia with t(8;21)(q22; q22) CNRS Inist Pascal-Francis …
duration and survival in acute myeloid Leukemia with t(8;21)(q22; q22) CNRS Inist Pascal-Francis …
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8; 21)(q22; q22).
MR Baer, CC Stewart, D Lawrence, DC Arthur, JC Byrd… - Blood, 1997 - europepmc.org
Although acute myeloid leukemia (AML) with t (8; 21)(q22; q22) is associated with a high
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
complete remission (CR) rate and prolonged disease-free survival, treatment outcome is not …
Expression of the Neural Cell Adhesion Molecule CD56 Is Associated With Short Remission Duration and Survival in Acute Myeloid Leukemia With t (8; 21)(q22; q22)
MR Baer, CC Stewart, D Lawrence, DC Arthur, JC Byrd… - Blood, 1997 - cir.nii.ac.jp
抄録< jats: p> Although acute myeloid leukemia (AML) with t (8; 21)(q22; q22) is associated
with a high complete remission (CR) rate and prolonged disease-free survival, treatment …
with a high complete remission (CR) rate and prolonged disease-free survival, treatment …